Introduction {#s0001}
============

Colon cancer is recognized as the third most common cancer worldwide with high morbidity and mortality, and the fourth common cause of death (Haggar and Boushey [@CIT0009]). The need to find alternative and new anticolon cancer agents was further triggered by the fact that most of the available therapeutic treatments, such as radiotherapy, chemotherapy and surgery, are afflicted with severe side effects (i.e., hair loss, immunosuppression, diarrhoea and bleeding) (Kranz and Dobbelstein [@CIT0013]). Thus, there is an urgent interest and demand in using plant phytoconstituents to identify novel chemotherapeutic agents that are more effective and have minimal adverse side effects.

One of the carcinogenic agents commonly use in colon cancer study is azoxymethane (AOM), which works via the modulation of mechanism that is oxidative stress dependent (Waly et al. [@CIT0025]). The ability of AOM to act as a procarcinogen in colon carcinogenicity is attributed to the formation of ultimate carcinogenic metabolite, the highly reactive methyldiazonium (MD) ion, which is responsible for lipid peroxidation that leads to oxidative stress and decrease in the total antioxidants capacity of colonic cells (Al-Numair et al. [@CIT0001]; Hamiza et al. [@CIT0010]). Specifically, AOM mediated the reduction of glutathione (GSH) leading to impairment in the total antioxidant capacity of rats colonic cells (Waly et al. [@CIT0025]). In addition, MD will cause alkylation of macromolecules in the liver and colon, as well as the addition of the methyl group at the O6 position of guanine. This will cause point mutation of (G:C) to (A:T) that caused changes from glycine to aspartic acid (Vogelstein et al. [@CIT0024]). Therefore, it is plausible to suggest that any compounds that are capable of attenuating oxidative stress might also have the ability to exert anticancer activity.

One of the plants that is postulated to possess anticancer activity is *Muntingia calabura* L. (Elaeocarpaceae). Throughout the world, *M. calabura* is well known as Jamaican cherry and, in Malaysia, it is locally known as 'kerukup siam' or 'buah ceri'. *Muntingia calabura* has a long history of native folk medicine among the peoples of Peru, Cambodia, Columbia, Vietnam and the Philippines (Mahmood et al. [@CIT0015]) and scientific studies carried out on the leaves, in particular, have demonstrated various medicinal activities such as cytotoxic, antiproliferative, anti-inflammatory and antioxidant (Mahmood et al. [@CIT0015]; Zakaria et al. [@CIT0026]; Rofiee et al. [@CIT0020]). Earlier cytotoxic study revealed the potential of several flavonoids (i.e., (2S)-5′-hydroxy-7,3′,4′-trimethoxyflavanone and 4′-hydroxy-7-methoxyflavanone) and chalcones (i.e., 2′,4′-dihydroxychalcone and 2′,4′-dihydroxy-3′-methoxychalcone) isolated from the leaves of *M. calabura* to inhibit the growth of HT-29 (colon cancer) cell lines (Mahmood et al. [@CIT0015]). Taking all these facts into account, the present study was performed to determine the anti-colon cancer activity of methanol extract of *M. calabura* leaves (MEMC~L~) against the AOM-induced colon cancer model in rats.

Materials and methods {#s0002}
=====================

Collection of plant materials and the preparation of MEMC~L~ {#s0003}
------------------------------------------------------------

The leaves of *M. calabura* were collected around Universiti Putra Malaysia (UPM), between July and December 2012. A voucher specimen (SK 2200/13) was identified by a botanist from the Institute of Bioscience, Universiti Putra Malaysia (UPM) by comparison with specimens available at the Herbarium of the Laboratory of Natural Products, Institute of Bioscience, UPM. The matured and dried leaves were powdered using a grinder into coarse powder. Briefly, 1 kg coarse powder of *M. calabura* was macerated within methanol (1:20, w/v) for 72 h in room temperature and this procedure was carried out three times using the same residue. The collected supernatant was pooled together and then evaporated using a rotary evaporator under reduced pressure.

Experimental animal {#s0004}
-------------------

The rats were kept in the standard condition of 12 h dark/light in the animal house of the Faculty of Medicine & Health Sciences, UPM. The animals were allowed free access to tap water and fed with standard pellet diet *ad libitium*. The study protocol of the present study was approved by the International Animal Care and Use Committee, Faculty of Medicine and Health Sciences, UPM (IACUC Ethical approval no. UPM/FPSK/PADS/BR-UUH/00488) and was conducted in accordance with international laws and policies (McPherson [@CIT0017]). Prior to the experimentation, the rats were divided into five groups (*n* = 7).

Anticarcinogenic study {#s0005}
----------------------

### Administration of carcinogen and MEMC~L~ {#s0006}

After 2 weeks of acclimatization, all animals received carcinogen injection (AOM; Sigma Chemical Co., St. Louis, MO) intraperitoneally at the dose of 15 mg/kg once weekly for 2 weeks except for the normal control group, which received normal saline (Group 1) (Ghafar et al. [@CIT0007]).

After the last administration of AOM, the rats in Groups 2, 3, 4 and 5 were treated with 8% Tween-80 (vehicle; cancer control group) or MEMC, at the doses of 50, 250 or 500 mg/kg, for 8 weeks in the volume of 10 mL/kg of body weight. On the contrary, the normal control group (Group 1) received normal saline. The body weight and the food intake of all rats were recorded weekly for the whole duration of the experiment. Each group and the respective treatment given are illustrated below:

  Groups                           Administration
  ----------- -------------------- -------------------------------
  Control     I (Normal control)   Normal saline + normal saline
              II (AOM control)     AOM + 8% Tween-80
  Treatment   III                  AOM + 50 mg/kg MEMC
              IV                   AOM + 250 mg/kg MEMC
              V                    AOM + 500 mg/kg MEMC

Colon sample collection {#s0007}
-----------------------

After 8 weeks of treatment, rats from each group were sacrificed to allow quantification of aberrant crypt foci. Colon was collected and opened longitudinally before washed with normal saline. The opened colon was separated into two halves of equal width. Half of the colon was pinned on a board with flat mucosal on the top and fixed in 10% formalin overnight. The tissue was subjected to haematoxylin and eosin (H&E) staining. The remaining of the colon tissues were homogenized for antioxidant study.

Histopathological examination and ACF counting {#s0008}
----------------------------------------------

Collected colon tissues were fixed in 10% formalin and each part of colon samples were examined and counted for the total of ACF formation. Generally, ACF can be distinguished from normal crypts based on the morphological crypt seen under microscope: (1) darker in stain; (2) the size is enlarged and elongated; (3) thick epithelial lining; and (4) often had oval or slit-like lumen.

Measurement of enzymatic activities of AOM-treated colon tissue homogenate {#s0009}
--------------------------------------------------------------------------

Approximately 100 mg of each colon tissue was homogenized in 1 mL of phosphate buffered saline (PBS) using a teflon homogenizer (Polytron, Heidolph, Germany). The tissue homogenate was then centrifuged at 4000 rpm at 4 °C for 25 min. The supernatant was collected and used for further assessment of enzymatic activities. The levels of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) were determined using commercial kits (Cayman Chemical, Ann Arbor, MI), according to the instructions from the vendor. Additionally, the determination of the levels of malondialdehyde (MDA) was also carried out using commercial kits (Cayman Chemical, Ann Arbor, MI), based on the protocols provided by the manufacturer.

Identification of flavonoids in MEMC~L~ {#s0010}
---------------------------------------

Briefly, MEMC~L~, dissolved in methanol, was injected into a HPLC system consisting of the Waters Delta 600 with 600 Controller, photodiode array detector (Waters 996) (Milford, MA) and a Phenomenex Luna column (5 µm; 4.6 mm i.d. × 250 mm) (Torrance, CA). Two eluents labelled as A and B, which consist of the respective 0.1% aqueous formic acid and acetonitrile, were used to elute the phytoconstituents. The eluents were injected in the volume of 10 µL under the flow rate of 1.0 mL/min and column oven temperature set at 27 °C. The eluent was monitored at 366 nm. The retention time and UV spectra of major peaks were analyzed. MEMC~L~ was then spiked with several standard pure flavonoids in order to determine their presence in the extract (Zakaria et al. [@CIT0026]).

UHPLC-ESI-MS analysis of MMMC at the ratio of 1:1 (v/v) {#s0011}
-------------------------------------------------------

The UHPLC-ESI-MS system consisted of Dionex Ultimate 3000 series including a binary pump with a built in solvent degasser, a diode-array detector, an autosampler equipped with a column oven and a column compartment (Thermo Fisher Scientific, San Jose, CA). The MMMC was separated on a Cortecs C18 column (1.6 µL, 2.1 × 50 mm I.D.; Waters Co., Milford, MA) maintained at 40 °C. The mobile phase consisted of a mixture 0.1% formic acid in water and a mixture 0.1% formic acid in acetonitrile. A constant flow of 0.3 mL/min was applied. The acetonitrile percentages were the following: 0--5 min, 20%; 5--17 min, linearly from 20% to 60%; 17--20 min, 90%; 20--22 min, linearly from 90% to 5%; 22--30 min (re-equilibration step), 5%. The effluent from the chromatographic column was injected (10 µL) into a linear Q Exactive ion-trap-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with an electrospray ionization (ESI) interface in the negative ion mode. The mass recognization was performed in a range of 150--1500 *m*/*z*. The main mass conditions were the followings: capillary temperature 320 °C, source voltage 3.2 kV, sheath gas (35 arbitrary units), auxiliary gas (15 arbitrary unit) and sweep gas (10 arbitrary unit). Nitrogen (\>99.98%) was employed as sheath gas, auxiliary and sweep gas. Instrument control and data acquisition were performed with Chameleon 6.8 software and Xcalibur 2.2 software (Thermo Fisher Scientific, San Jose, CA).

Statistical analysis {#s0012}
--------------------

All data are presented as mean ± standard error of mean (SEM). Analyses of data were performed using the one-way analysis of variance (ANOVA) followed by the Dunnet *post hoc* test using the GraphPad Prism statistical software (version 5, GraphPad Software, La Jolla, CA). The *p* \< 0.05 was set as the limit of significance.

Results {#s0013}
=======

Effect of MEMC~L~ on body weight and relative organ weight of carcinogen-treated rats {#s0014}
-------------------------------------------------------------------------------------

The change in body weight throughout the study is summarized in [Figure 1](#F0001){ref-type="fig"}. In general, all rats in Groups 1, 3, 4 and 5 showed an increase in the body weight except for Group 2 (cancer group), which showed a decrease in the body weight at the end of the experiment. However, no significant different (*p* \> 0.05) observed in the relative organ/body weight ratio among the tested groups ([Table 1](#t0001){ref-type="table"}).

![Body weight for male Sprague--Dawley rats for colon cancer chemopreventive study.](IPHB_A_1371769_F0001_C){#F0001}

![(a) Normal histoarchitecture of rat colon; (b) AOM control group; (c) section of colon tissue treated with AOM + 50 mg/kg MEMC; (d) section of colon tissue treated with AOM + 250 mg/kg MEMC; (e) section of colon tissue treated with AOM + 500 mg/kg MEMC (I -- Infiltration of inflammatory cells. Black arrow -- Aberrant crypt foci) (100 × magnification).](IPHB_A_1371769_F0002_C){#F0002}

###### 

Effect of MEMC on relative organ weigh (ROW) in AOM-treated rats.

  \% Organ weight/body weight   Normal control (normal saline alone)   Positive control (AOM alone)   AOM + 50mg/kg MEMC   AOM + 250mg/kg MEMC   AOM + 500 mg/kg MEMC
  ----------------------------- -------------------------------------- ------------------------------ -------------------- --------------------- -----------------------------------------------
  Spleen                        0.232 ± 0.0398                         0.257 ± 0.0296                 0.275 ± 0.0161       0.295 ± 0.0361        0.347 ± 0.0186[\*](#TF2){ref-type="table-fn"}
  Heart                         0.434 ± 0.0376                         0.409 ± 0.0204                 0.425 ± 0.0189       0356 ± 0.0224         0.434 ± 0.0328
  Liver                         2.654 ± 0.2637                         2.951 ± 0.2124                 3.037 ± 0.1840       2.868 ± 0.2441        3.520 ± 0.3584
  Kidney                        0.7814 ± 0.0552                        0.796 ± 0.0295                 0.762 ± 0.0251       0.804 ± 0.0334        0.982 ± 0.0676[\*](#TF2){ref-type="table-fn"}
  Lung                          0.823 ± 0.0764                         0.951 ± 0.0689                 0.826 ± 0.0634       0.940 ± 0.1161        1.141 ± 0.1247
  Colon                         0.809 ± 0.0659                         0.934 ± 0.0719                 0.859 ± 0.0674       0.856 ± 0.0893        1.048 ± 0.1128

Values are expressed as means ± SEM.

\* Significant different as compared to normal control, *p* \< 0.05.

Effect of MEMC~L~ on the incidence of ACF formation in AOM-treated colon of rats {#s0015}
--------------------------------------------------------------------------------

The effect of MEMC~L~, at all tested doses, against AOM-induced ACF formation in carcinogenic rats is summarized in [Table 2](#t0002){ref-type="table"}. All rats in the cancer group (Group 2) that received (AOM +8% Tween 80) demonstrated a 100% incidence of ACF formation whereas no ACF was detected in the normal group (Group I) that received (normal saline +8% Tween 80). There was also significant reduction in the number of ACF formed when comparison was made between the 500 mg/kg of MEMC~L~-treated group against the cancer group (Group 2). Higher number of ACF was observed in the distal part of colon for the cancer group and MEMC~L~-treated groups. The reduction in percentage of ACF formation recorded for the MEMC~L~-treated groups in comparison with the cancer group ranged between 21% and 55% ([Figure 2](#F0002){ref-type="fig"}).

###### 

The incidence of aberrant crypt foci (ACF) found in rats colon induced by azoxymethane (AOM).

                                                                                                   Incidence of ACF                                                                                  Reduction as compared
  ----- ---------------------- -------------------------------------------------- ---------------- ------------------------------------------------ ------------------------------------------------ -----------------------
  I     Normal control         0.00 ± 0.00                                        0.00 ± 0.00      0.00 ± 0.00                                      0.00 ± 0.00                                       
  II    AOM control            33.00 ± 3.055                                      27.0 0 ± 2.887   47.67 ± 3.480                                    107.7 ± 6.489                                     
  III   AOM + 50 mg/kg MEMC    24.67 ± 1.333[\*](#TF8){ref-type="table-fn"}       27.33 ± 4.910    33.33 ± 5.696                                    85.33 ± 9.563                                    20.77%
  IV    AOM + 250 mg/kg MEMC   23.0 ± 0.577[\*\*](#TF8){ref-type="table-fn"}      25.0 ± 2.517     28.0 ± 3.512[\*](#TF8){ref-type="table-fn"}      76.0 ± 6.000                                     29.43%
  V     AOM + 500 mg/kg MEMC   14.33 ± 1.453[\*\*\*](#TF8){ref-type="table-fn"}   19.67 ± 1.667    23.00 ± 4.509[\*\*](#TF8){ref-type="table-fn"}   48.33 ± 13.48[\*\*](#TF8){ref-type="table-fn"}   55.13%

Values are expressed as means ± S.E.M.

\* Significant different as compared to AOM control, *p* \< 0.05.

\*\* Significant different as compared to AOM control, *p* \< 0.01.

\*\*\* Significant different as compared to AOM control, *p* \< 0.001.

Effect of MEMC~L~ on antioxidant activities of AOM-treated colon tissue homogenate {#s0016}
----------------------------------------------------------------------------------

[Table 3](#t0003){ref-type="table"} shows the level of SOD, CAT, GSH and MDA in AOM-treated colon following treatment with MEMC~L~. There was a significant (*p* \< 0.05) decrease in the SOD level in Group 2 (cancer group) due to the action of AOM alone. However, pretreatment with MEMC~L~, at all doses, significantly (*p* \< 0.05) reversed the AOM action on SOD level and increased the enzyme\'s level towards the normal value.

###### 

Effect of antioxidant enzymes in the colons of rats subjected to MEMC treatment.

                                                                                               Antioxidant assays                                                                                     
  ---------------- ---------------------- ---------------------------------------------------- ------------------------------------------------- --------------------------------------------------- ----------------------------------------------------
  AOM control      AOM                    0.6473 ± 0.2107                                      95.33 ± 1.202                                     16.55 ± 1.913                                       3.097 ± 0.2621
  Normal control   Normal saline          2.672 ± 0.1521[\*\*\*](#TF12){ref-type="table-fn"}   103.4 ± 0.1764                                    39.57 ± 4.534[\*\*\*](#TF12){ref-type="table-fn"}   1.520 ± 0.2403[\*\*](#TF12){ref-type="table-fn"}
  Treatment        AOM + 50 mg/kg MEMC    2.104 ± 0.0610[\*\*\*](#TF12){ref-type="table-fn"}   101.9 ± 0.03333                                   23.13 ± 0.777[\*](#TF12){ref-type="table-fn"}       2.460 ± 0.2879[\*](#TF12){ref-type="table-fn"}
  Treatment        AOM + 250 mg/kg MEMC   2.352 ± 0.0706[\*\*\*](#TF12){ref-type="table-fn"}   102.7 ± 0.0[\*](#TF12){ref-type="table-fn"}       25.41 ± 1.150[\*](#TF12){ref-type="table-fn"}       2.343 ± 0.2418[\*](#TF12){ref-type="table-fn"}
  Treatment        AOM + 500 mg/kg MEMC   2.526 ± 0.0878[\*\*\*](#TF12){ref-type="table-fn"}   108.1 ± 4.942[\*\*](#TF12){ref-type="table-fn"}   32.06 ± 1.782[\*\*](#TF12){ref-type="table-fn"}     1.200 ± 0.1015[\*\*\*](#TF12){ref-type="table-fn"}

Values are expressed as means ± S.E.M.

\* Significant different as compared to AOM control, *p* \< 0.05.

\*\* Significant different as compared to AOM control, *p* \< 0.01.

\*\*\* Significant different as compared to AOM control, *p* \< 0.001.

The amount of CAT activity in the cancer group (Group 2) was also significantly (*p* \< 0.05) reduced in comparison with the normal group (Group 1). Treatment with MEMC~L~, at 500 mg/kg, caused significant (*p* \< 0.05) elevation in the level of CAT activity in comparison with the cancer group (Group 2).

The level of GSH was significantly (*p* \< 0.05) depleted in cancer group (Group 2) when compared with the normal group (group 1). MEMC~L~ treatment increased the GSH level when compared with the cancer group.

As seen in [Table 3](#t0003){ref-type="table"}, the level of MDA was significantly (*p* \< 0.05) elevated in the cancer group when compared with the normal group. Treatment with MEMC~L~ caused significant (*p* \< 0.05) reduction in the MDA level towards the normal value in a dose-dependent manner.

Identification of flavonoid in MEMC~L~ via HPLC analysis {#s0017}
--------------------------------------------------------

[Figure 3](#F0003){ref-type="fig"} shows the HPLC profile of MEMC~L~ wherein five major peaks were detected. However, comparison with the respective chromatogram of several pure flavonoids mentioned earlier at 366 nm demonstrated that only rutin peak matched peak number 2 in the chromatogram of MEMC~L~.

###### 

Comparison between chromatogram of the standard compound (A) rutin and (B) quercitrin with the chromatogram of MEMC at 366 nm showing that the peak of rutin was parallel to one of the peaks presence in MEMC.

![](IPHB_A_1371769_F0003a_C){#F0003a}

![](IPHB_A_1371769_F0003b_C){#F0003b}

Identification of phenolic compounds in MEMC~L~ using the UHPLC--ESI-MS {#s0018}
-----------------------------------------------------------------------

The phenolic compounds profile of MEMC~L~ obtained via the UHPLC-ESI-MS analysis is shown in [Figure 4](#F0004){ref-type="fig"}. The chromatogram obtained following the analysis shows the presence of various peaks of which 13 peaks were identified as listed in [Table 4](#t0004){ref-type="table"}.

![Total ion chromatography (TIC) of MEMC obtained using the UHPLC instrument in negative ion mode.](IPHB_A_1371769_F0004_B){#F0004}

###### 

Phenolic compounds identified in MMCL by UHPLC-MS.

  Peak no.   *t*^R^ (min)   \[M--H\]--   Error (ppm)   Formula           Identification
  ---------- -------------- ------------ ------------- ----------------- ------------------------------
  1\.        0.46           169.01392    5.090         C~7~H~5~O~5~      Gallic acid
  2\.        3.16           193.05023    3.599         C~10~H~9~O~4~     Ferulic acid
  3\.        4.58           599.10559    4.079         C~28~H~23~O~15~   Quercitrin-2″-*O*-gallate
  4\.        5.08           447.09439    4.926         C~21~H~19~O~11~   Kaempferol-3-*O*-galactoside
  5\.        5.39           463.08957    5.392         C~15~H~9~O~8~     Quercetin-3-*O*-galactoside
  6\.        6.96           583.11093    4.576         C~28~H~23~O~14~   Afzelin-*O*-gallate
  7\.        7.44           603.07947    4.209         C~30~H~19~O~14~   Quercetin dimer
  8\.        8.12           593.13110    3.596         C~30~H~25~O~13~   Kaempferol-3-*O*-glucoside
  9\.        8.57           271.06100    3.321         C~15~H~12~O~5~    Pinobaksin
  10\.       11.45          255.06644    4.919         C~15~H~11~O~4~    Pinocembrin (isomer 2)
  11\.       11.92          299.05606    3.496         C~16~H~11~O~6~    Kaempferide I
  12\.       12.39          299.05649    4.934         C~16~H~11~O~6~    Kaempferide II
  13\.       12.78          313.07214    4.713         C~17~H~13~O~6~    Ermanin II

Discussion {#s0019}
==========

The present study for the first time reported on the anti-colon cancer potential of MEMC~L~ against AOM-induced colon cancer in rats model hence confirmed the previous claims on the association between the antioxidant and anti-inflammatory activities as a part of the mechanisms of anticancer activity (Henley [@CIT0011]; Devasagayam et al. [@CIT0005]; Rayburn et al. [@CIT0019]; Waly et al. [@CIT0025]). Besides, this study further had proven the presence of anti-colon cancer activity in MEMC~L~ via an *in vivo* model, which supported earlier findings using the *in vitro* model (Mahmood et al. [@CIT0015]). In addition, the present study also confirmed on the ability of MEMC~L~ to modulate the endogenous antioxidant system consisting of SOD, CAT, GSH and MDA as a part of the anticarcinogenesis mechanisms against the action of AOM (Waly et al. [@CIT0025]). Furthermore, MEMC~L~ feeding did not affect the body weight gain profiles, which is consistent with previous anti-cancer efficacy studies using the same cancer models (Derry et al. [@CIT0004]).

AOM can trigger oxidative and DNA damage following its administration due to its highly reactive metabolite that is methyldiazonium ion, which can trigger mutagenicity by initiating chromosomal damage and induction of micronuclei (MN) cells, results in colonic morphological changes associated with aberrant crypt foci (ACF) development. ACF are putative preneoplastic lesions that appear as abnormally large, darkly stained and slightly elevated from the normal crypt, display an irregular glandular architecture at epithelial region and have possibility to develop into colorectal cancer. Normally, it can be seen as early as 2--4 weeks after carcinogen administration (Caderni et al. [@CIT0002]). The ability of MEMC~L~ to reduce the ACF count might also be attributed partly to the extract high antioxidants content and ability to modulate the endogenous antioxidant system within the colon tissue.

One of the potent intracellular antioxidants to eliminate the oxidative stress is GSH. The antioxidant capability of GSH is achieved by direct interaction of the --SH group with ROS or work as coenzyme to detoxify the ROS reaction (Hamiza et al. [@CIT0010]). As described earlier, AOM induces oxidative stress by depleting the level of GSH; in the present study treatment with MEMC~L~ restores the GSH level indicating the protective effect of MEMC~L~. Besides GSH, AOM also depleted the level of CAT and SOD, which was reverse and restore back towards normal value by MEMC~L~. The administration of AOM also induced a marked increase in MDA level, which was reduced by MEMC~L~ indicating the cytoprotective action of the extract.

Following the administration of AOM, marked inflammation was observed in the colonic tissue surrounding the ACF area suggesting that the AOM-induced oxidative stress was partly mediated by an inflammatory response. It is well acknowledged that the inflammatory process was a part of the cells natural defence against tissue damage, which was generally associated with oxidative stress (Henley [@CIT0011]; Rayburn et al. [@CIT0019]). The presence of inflammatory cells in the AOM-treated group was remarkably attenuated by the MEMC, as the plant reported previously to have anti-inflammatory properties (Mahmood et al. [@CIT0015]).

In the present study, rutin was detected in MEMC~L~ via the HPLC analysis at 366 nm. This compound has been reported to exert antioxidant, anti-inflammatory activities (Gautam et al. [@CIT0006]) and anti-colon cancer activity (Volate et al. [@CIT0023]). Rutin has been shown to target different modulators of Wnt signalling intracellularly (Perk et al. 2014), this action perhaps can cause negative modulation of APC gene (adenomatous polyposis coli). *APC* is one of the genes that directly involves in carcinogenesis of colon cancer, thus preventing the *APC* gene forming its complex transcriptional factor might inhibit the early stage of colon cancer by *M. calabura* leaves.

Further subjection of MEMC~L~ to the UHPLC-ESI-MS analysis demonstrated the presence of various polyphenolic compounds as indicated by the presence of a range of peaks. Of these, 13 peaks were identified to represent the respective bioactive compounds ([Table 4](#t0004){ref-type="table"}) and, interestingly, some of these compounds, such as gallic acid, ferulic acid and pinocembrin, have been reported to exert anticarcinogenic activity. Gallic acid exerts an anticarcinogenic activity against 1,2-dimethylhydrazine (DMH) induced colon carcinogenesis in rats via modulation of the endogenous antioxidant defence system (Giftson et al. [@CIT0008]). Furthermore, gallic acid, the active component of grape seed procyanidins, has also been reported to show antiproliferative and antiapoptotic activities against pancreatic cancer cells (Cedó et al. [@CIT0003]). In addition, gallic acid was also proven to exert a radical scavenging ability toward OH and OOH radicals (Marino et al. [@CIT0016]). Ferulic acid has also been reported to exert an anticarcinogenic activity against azoxymethane-induced colon carcinogenesis (Kawabata et al. [@CIT0012]) possibly via the reduction of proliferative activity and the induction of apoptosis in cancer cells (Srinivasan et al. [@CIT0022]). Moreover, Srinivasan et al. ([@CIT0022]) also cited the ability of ferulic acid to exert antioxidant and anti-inflammatory activities, which are generally known to play part in the mechanism of anticancer. Pinocembrin has also been cited to possess antioxidant, anti-inflammatory and anticancer activities (Santos et al. [@CIT0021]; Liu et al. [@CIT0014]; Rasul et al. [@CIT0018]). Based on these reports, it is plausible to suggest that MEMC~L~ exerts an anticarcinogenic activity against AOM-induced colon cancer in rats partly through the synergistic action of these chemicals.

Conclusions {#s0020}
===========

In conclusion, the results of this study suggested that MEMC~L~ has a potential effect against the AOM induced colonic preneoplastic progression in Sprague--Dawley rats. Besides, this study also demonstrated the administration of MEMC~L~ attenuates the AOM-induced alterations at lipid peroxidation level and in the overall antioxidants enzymatic status of the rat′s colon. MEMC~L~ may have potential as chemoprevention agent possibly by reducing the colonic oxidative stress, increasing the antioxidants levels possibly via the synergistic action of several flavonoids, including rutin, gallic acid, ferulic acid and pinocembrin.
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